Good News: FDA Approves Gene Therapy for Cancer. Bad News: It Costs $475k – Healthcare Packaging
Healthcare Packaging |
Good News: FDA Approves Gene Therapy for Cancer. Bad News: It Costs $475k
Healthcare Packaging A recent article from MIT Technology Review discussed the FDA's approval of a groundbreaking gene therapy for cancer that uses genetically engineered immune cells. The process, developed by Novartis, is known as a CAR-T therapy and it will cost … |
